Loading institutional data...
Loading institutional data...
Held by 200 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $19.39 today, the market must believe free cash flow compounds -3.5%/yr for a decade (off $74M normalized FCF).
2-stage DCF · 0.04B shares · net debt -$157M
mean 3.1% · volatility σ 200% · implied rate exceeded in 2/6 yrs
Central path = implied -3.5%/yr growth; shaded band = ±1σ (200%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $13M buybacks = $13M returned on -$93M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: -0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~10.2% on $26M of debt. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B 100.0% | $1.08B 100.0% | $1.36B 100.0% | $1.33B 100.0% | $1.28B 100.0% | $830.7M 100.0% | $1.21B 100.0% | $1.61B 100.0% | $1.33B 100.0% | $869.5M 100.0% |
| Cost of Revenue | $1.06B 91.8% | $986.3M 91.0% | $1.18B 86.3% | $1.20B 90.5% | $1.06B 82.9% | $815.1M 98.1% | $1.19B 98.1% | $1.48B 92.1% | $1.25B 94.0% | $841.6M 96.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $1.26B 94.9% | $841.6M 96.8% |
| Gross Profit | $95.1M 8.2% | $97.7M 9.0% | $186.5M 13.7% | $126.7M 9.5% | $220.0M 17.1% | $15.6M 1.9% | $22.6M 1.9% | $126.6M 7.9% | $80.3M 6.0% | $27.9M 3.2% |
| Research & Development | — | — | — | $800K 0.1% | $1.7M 0.1% | $1.8M 0.2% | $4.1M 0.3% | $8.1M 0.5% | $8.0M 0.6% | $8.0M 0.9% |
| Selling, General & Admin | $94.0M 8.1% | $87.7M 8.1% | $84.6M 6.2% | $73.8M 5.5% | $77.2M 6.0% | $76.7M 9.2% | $91.8M 7.6% | $98.2M 6.1% | $90.5M 6.8% | $90.2M 10.4% |
| Operating Income | — | — | — | — | — | — | — | $5.8M 0.4% | -$23.4M -1.8% | -$62.6M -7.2% |
| Interest Expense | — | — | $2.7M 0.2% | $3.9M 0.3% | $6.2M 0.5% | $12.6M 1.5% | $15.7M 1.3% | $17.1M 1.1% | $14.8M 1.1% | $11.4M 1.3% |
| Interest & Investment Income | $6.7M 0.6% | $12.1M 1.1% | $9.8M 0.7% | $3.3M 0.2% | $300K 0.0% | $400K 0.0% | — | — | — | — |
| Other Income (Expense), net | $900K 0.1% | -$5.0M -0.5% | -$3.7M -0.3% | $90.6M 6.8% | $59.5M 4.6% | $14.2M 1.7% | -$23.3M -1.9% | -$18.6M -1.2% | -$4.1M -0.3% | -$68.0M -7.8% |
| Pretax Income | $1.9M 0.2% | $4.6M 0.4% | $96.4M 7.1% | $97.1M 7.3% | $176.7M 13.8% | -$60.7M -7.3% | -$126.1M -10.4% | -$8.2M -0.5% | -$29.8M -2.2% | -$142.0M -16.3% |
| Income Tax Expense | $3.1M 0.3% | $3.3M 0.3% | $27.0M 2.0% | $32.0M 2.4% | $5.7M 0.4% | $1.2M 0.1% | -$16.1M -1.3% | $1.8M 0.1% | $1.5M 0.1% | -$36.5M -4.2% |
| Net Income | -$1.2M -0.1% | $1.3M 0.1% | $69.4M 5.1% | $65.1M 4.9% | $171.0M 13.3% | -$61.9M -7.5% | -$110.0M -9.1% | -$10.0M -0.6% | -$31.3M -2.4% | -$105.5M -12.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.03 | $0.03 | $1.58 | $1.42 | $3.73 | $-1.38 | $-2.46 | $-0.22 | $-0.70 | $-2.39 |
| EPS (Diluted) | $-0.03 | $0.03 | $1.47 | $1.30 | $3.18 | $-1.38 | $-2.46 | $-0.22 | $-0.70 | $-2.39 |
| Weighted Avg Shares (Basic) | 41.9M | 43.2M | 43.8M | 45.8M | 45.9M | 45.0M | 44.8M | 44.6M | 44.4M | 44.2M |
| Weighted Avg Shares (Diluted) | 41.9M | 44.3M | 47.8M | 51.5M | 55.0M | 45.0M | 44.8M | 44.6M | 44.4M | 44.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 12-yr range · 75th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 92.1 | 98.1 | 98.1 | 82.9 | 90.5 | 86.3 | 91.0 | 91.8 |
| Gross Profit | 7.9 | 1.9 | 1.9 | 17.1 | 9.5 | 13.7 | 9.0 | 8.2 |
| R&D | 0.5 | 0.3 | 0.2 | 0.1 | 0.1 | — | — | — |
| SG&A | 6.1 | 7.6 | 9.2 | 6.0 | 5.5 | 6.2 | 8.1 | 8.1 |
| Operating Income | 0.4 | — | — | — | — | — | — | — |
| Income Tax | 0.1 | -1.3 | 0.1 | 0.4 | 2.4 | 2.0 | 0.3 | 0.3 |
| Net Income | -0.6 | -9.1 | -7.5 | 13.3 | 4.9 | 5.1 | 0.1 | -0.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MTUS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 238 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BHP | $439.4B | — | — | — | — | — | — | — | — | — | 713 |
| LIN | $215.3B | 31.4× | 19.3× | 6.3× | 3.0% | — | 20.3% | 18.0% | 10.9% | 2.1× | 2,148 |
| SCCO | $162.1B | 37.4× | 20.9× | 12.1× | 17.4% | 60.1% | 32.4% | 39.4% | 24.4% | 0.9× | 791 |
| CX | $147.8B | — | — | — | — | — | — | — | — | — | 297 |
| TX | $116.5B | — | — | — | — | — | — | — | — | — | 139 |
| FCX | $101.8B | — | 12.3× | 3.9× | 1.8% | 28.2% | 16.0% | 22.0% | 14.7% | 1.1× | 1,775 |
| AEM | $100.7B | — | — | — | — | — | — | — | — | — | 1,066 |
| SHW | $79.5B | 31.3× | — | 3.4× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | — | 1,610 |
| ECL | $76.6B | 37.3× | 22.5× | 4.8× | 2.2% | 44.5% | 12.9% | 21.2% | 19.5% | 0.3× | 1,619 |
| B | $73.2B | — | — | — | — | — | — | — | — | — | 979 |
| WPM | $69.1B | — | — | — | — | — | — | — | — | — | 809 |
| APD | $63.7B | — | 90.0× | 5.3× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | 0.1× | 1,702 |
| VALE | $61.6B | — | — | — | — | — | — | — | — | — | 537 |
| NUE | $61.2B | 35.3× | — | 1.9× | 5.7% | 11.9% | 5.4% | 8.3% | 8.3% | — | 1,325 |
| CRH | $58.0B | 15.7× | 9.3× | 1.6× | 5.3% | 36.1% | 10.0% | 15.6% | 9.2% | 2.2× | 9 |
| MT | $57.2B | — | — | — | — | — | — | — | — | — | 286 |
| DD | $53.6B | — | — | 7.8× | 1.9% | 34.5% | -11.4% | -5.6% | -5.6% | — | 1,172 |
| AU | $51.7B | — | — | — | — | — | — | — | — | — | 537 |
| FNV | $51.4B | — | — | — | — | — | — | — | — | — | 614 |
| NTR | $37.7B | — | — | — | — | — | — | — | — | — | 718 |
| STLD | $35.6B | 30.7× | 19.2× | 2.0× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 2.1× | 893 |
| KGC | $34.2B | — | — | — | — | — | — | — | — | — | 630 |
| VMC | $31.9B | 30.1× | 15.3× | 4.0× | 7.1% | 27.4% | 13.6% | 12.6% | 8.4% | 1.8× | 981 |
| MLM | $29.8B | 26.3× | 16.9× | 4.8× | 8.6% | 30.7% | 18.5% | 11.3% | 7.4% | 2.6× | 1,022 |
| PPG | $23.6B | 15.2× | — | 1.5× | 0.2% | 41.3% | 9.9% | 19.8% | 10.3% | — | 1,003 |
| MTUS | $812M | — | — | 0.7× | 6.9% | 8.2% | -0.1% | -0.2% | -0.2% | — | 200 |
Peers = companies sharing MTUS's sector (Basic Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.